Viracta Therapeutics, Inc.
General ticker "VIRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.0M (TTM average)
Viracta Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -6.1%.
Estimated limits based on current volatility of 0.0%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 40 (+25.0%) as of 2023
- Top business risk factors: Liquidity and credit risks, Regulatory and compliance, Clinical trial delays, Dependence on lead product, Economic downturns and volatility
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.28$, 0.99$]
- 2024-12-30 to 2025-12-30 estimated range: [0.24$, 0.79$]
Financial Metrics affecting the VIRX estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 18.93 < Shareholder equity ratio, % of 32.31 <= 41.86
- Positive: Investing cash flow per share per price, % of 76.32 > -0.66
- Positive: Inventory ratio change, % of -100 <= -0.75
- Negative: Operating cash flow per share per price, % of -203.00 <= 0.33
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term VIRX quotes
Long-term VIRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $-62.50MM | $50.59MM | $50.69MM |
| Operating Income | $62.50MM | $-50.59MM | $-50.69MM |
| Non-Operating Income | $-177.26MM | $2.61MM | $-0.18MM |
| Interest Expense | $0.49MM | $0.58MM | $3.70MM |
| R&D Expense | $23.86MM | $26.26MM | $33.37MM |
| Income(Loss) | $-114.76MM | $-47.98MM | $-50.87MM |
| Profit(Loss)* | $-203.06MM | $-49.77MM | $-51.06MM |
| Stockholders Equity | $94.37MM | $61.10MM | $18.32MM |
| Inventory | $0.00MM | $0.91MM | $0.00MM |
| Assets | $108.55MM | $95.99MM | $56.69MM |
| Operating Cash Flow | $-18.85MM | $-35.46MM | $-39.89MM |
| Capital expenditure | $4.25MM | $0.04MM | $0.14MM |
| Investing Cash Flow | $12.89MM | $-53.87MM | $15.00MM |
| Financing Cash Flow | $62.42MM | $22.54MM | $0.44MM |
| Earnings Per Share** | $-6.37 | $-1.32 | $-1.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.